De Faakto

De Faakto OSINT Analysis-Criminal/Terrorist Drone Hazard

De Faakto Intelligence Research Observatory Criminal/Terrorist Drone Hazard Methodology-OSINT research Situation Airborne Drone Hazard-Improvised Explosive Device Attacks, Surreptitious Surveillance, Other High Risk Drone…

ALERT-FDA-Losartan Potassium and Hydrochlorothiazide

Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of…

Recall of Puriton Eye Relief Drops

From the U.S. Food & Drug Administration Kadesh Incorporation Issues Voluntary Nationwide Recall of Puriton Eye Relief Drops Due to…

ALERT-FDA-DRUG SHORTAGE-DIAZEPAM & VOLUNTARY RECALL ORTHO-NOVUM

From the Food & Drug Administration Diazepam Injection Status: Currently in Shortage Date first posted: 09/22/2017 Therapeutic Categories: Neurology Hospira Inc. 10 mg/2 mL (5…

Chemical Weapons Syria-Faaktboard-OSINT Analysis

De Faakto Intelligence Research Observatory Chemical Weapons Syria-Faaktboard-OSINT Analysis Methodology OSINT-research Situation Chemical Weapons Syria Background Syria is thought to have had the largest chemical weapons…

ALERT-FDA-EPIPEN AUTO-INJECTOR

ALERT-Food & Drug Administration Epipen Auto-Injector FDA alerts patients and health care professionals that some EpiPen auto-injectors may not readily…

MEDICAL-ALERT-FDA-Multiple Safety

MEDICAL ALERT Food & Drug Administration 1. Maquet Datascope Corp./Getinge Group Recalls the Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon…

FDA approves new drug to treat influenza-Xofluza (baloxavir marboxil)

Food & Drug Administration approves new drug to treat influenza Xofluza (baloxavir marboxil) Today, the U.S. Food and Drug Administration approved…

De Faakto Intelligence-Women in Combat-an Open Source Study

De Faakto Intelligence Research Observatory   Women in Combat-an Open Source Study Methodology OSINT-research Gaps Disparate Information Situation Combat…

Alert FDA Drug Safety-Recall

From the U.S. Food & Drug Administration   Irbesartan Tablets Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75…